Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/44131
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorToro Londoño, Miguel Ángel-
dc.contributor.authorde Lucio, Héctor-
dc.contributor.authorGarcía Marín, Javier-
dc.contributor.authorSánchez Alonso, Patricia-
dc.contributor.authorGarcía-Soriano, Juan Carlos-
dc.contributor.authorVaquero, Juan J.-
dc.contributor.authorGago, Federico-
dc.contributor.authorAlajarín, Ramón-
dc.contributor.authorJiménez Ruiz, Antonio-
dc.date.accessioned2024-12-16T16:16:16Z-
dc.date.available2024-12-16T16:16:16Z-
dc.date.issued2022-
dc.identifier.citationde Lucio H, García-Marín J, Sánchez-Alonso P, García-Soriano JC, Toro MÁ, Vaquero JJ, Gago F, Alajarín R, Jiménez-Ruiz A. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase. Eur J Med Chem. 2022 Jan 5;227:113915. doi: 10.1016/j.ejmech.2021.113915.spa
dc.identifier.issn0223-5234-
dc.identifier.urihttps://hdl.handle.net/10495/44131-
dc.description.abstractABSTRACT: Fifteen pyridazino-pyrrolo-quinoxalinium salts were synthesized and tested for their antiprotozoal activity against Leishmania infantum amastigotes. Eleven of them turned out to be leishmanicidal, with EC50 values in the nanomolar range, and displayed low toxicity against the human THP-1 cell line. Selectivity indices for these compounds range from 10 to more than 1000. Compounds 3b and 3f behave as potent inhibitors of the oxidoreductase activity of the essential enzyme trypanothione disulfide reductase (TryR). Interestingly, binding of 3f is not affected by high trypanothione concentrations, as revealed by the noncompetitive pattern of inhibition observed when tested in the presence of increasing concentrations of this substrate. Furthermore, when analyzed at varying NADPH concentrations, the characteristic pattern of hyperbolic uncompetitive inhibition supports the view that binding of NADPH to TryR is a prerequisite for inhibitor-protein association. Similar to other TryR uncompetitive inhibitors for NADPH, 3f is responsible for TryR-dependent reduction of cytochrome c in a reaction that is typically inhibited by superoxide dismutase.spa
dc.format.extent13 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titlePyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductasespa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupGrupo de Parasitología, Universidad de Antioquiaspa
dc.identifier.doi10.1016/j.ejmech.2021.113915-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn1768-3254-
oaire.citationtitleEuropean Journal of Medicinal Chemistryspa
oaire.citationstartpage1spa
oaire.citationendpage13spa
oaire.citationvolume227spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
oaire.fundernameMinisterio de Ciencia, Innovación y Universidadesspa
oaire.fundernameComunidad de Madridspa
oaire.fundernameInstituto de Salud Carlos IIIspa
dc.publisher.placeParís, Franciaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsAntiprotozoarios-
dc.subject.decsAntiprotozoal Agents-
dc.subject.decsRelación Dosis-Respuesta a Droga-
dc.subject.decsDose-Response Relationship, Drug-
dc.subject.decsInhibidores Enzimáticos-
dc.subject.decsEnzyme Inhibitors-
dc.subject.decsLeishmania infantum-
dc.subject.decsEstructura Molecular-
dc.subject.decsMolecular Structure-
dc.subject.decsNADH NADPH Oxidorreductasas-
dc.subject.decsNADH, NADPH Oxidoreductases-
dc.subject.decsPruebas de Sensibilidad Parasitaria-
dc.subject.decsParasitic Sensitivity Tests-
dc.subject.decsPiridazinas-
dc.subject.decsPyridazines-
dc.subject.decsPirroles-
dc.subject.decsPyrroles-
dc.subject.decsQuinoxalinas-
dc.subject.decsQuinoxalines-
dc.subject.decsSales (Química)-
dc.subject.decsSalts-
dc.subject.decsRelación Estructura-Actividad-
dc.subject.decsStructure-Activity Relationship-
dc.subject.decsCélulas THP-1-
dc.subject.decsTHP-1 Cells-
oaire.awardtitlePLATESA2-CMspa
oaire.awardtitleNOVELRENspa
oaire.awardtitleFEDERspa
oaire.awardtitleRETIC REDINRENspa
dc.description.researchgroupidCOL0007506spa
oaire.awardnumberPID2019-104070RB-C22spa
oaire.awardnumberPCTQ2017-85263-Rspa
oaire.awardnumberB2017/BMD-3751spa
oaire.awardnumberRD16/0009/0015spa
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000981-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004305-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D004791-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D018314-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D015394-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D009247-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D021261-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011724-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011758-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D011810-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D012492-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D013329-
dc.subject.meshurihttps://id.nlm.nih.gov/mesh/D000074084-
dc.relation.ispartofjournalabbrevEur. J. Med. Chem.spa
oaire.funderidentifier.rorRoR:05r0vyz12-
oaire.funderidentifier.rorRoR:040scgh75-
oaire.funderidentifier.rorRoR:00ca2c886-
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
ToroMiguel_2022_Pyridazino_Pyrrolo_Quinoxalinium.pdfArtículo de investigación1.08 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons